Search filters

List of works by Yun Dai

A Bim-targeting strategy overcomes adaptive bortezomib resistance in myeloma through a novel link between autophagy and apoptosis

scientific article

ARNT/HIF-1β links high-risk 1q21 gain and microenvironmental hypoxia to drug resistance and poor prognosis in multiple myeloma

scientific article published on 21 June 2018

CHK1 Inhibitors in Combination Chemotherapy: Thinking Beyond the Cell Cycle

scientific article published on April 1, 2011

Disruption of IκB Kinase (IKK)-mediated RelA Serine 536 Phosphorylation Sensitizes Human Multiple Myeloma Cells to Histone Deacetylase (HDAC) Inhibitors

scientific article published on August 4, 2011

Disruption of Src function potentiates Chk1-inhibitor–induced apoptosis in human multiple myeloma cells in vitro and in vivo

scientific article published on December 10, 2010

Enhancing CHK1 inhibitor lethality in glioblastoma

scientific article published on April 1, 2012

HDAC Inhibitors Potentiate the Activity of the BCR/ABL Kinase Inhibitor KW-2449 in Imatinib-Sensitive or -Resistant BCR/ABL+ Leukemia Cells In Vitro and In Vivo

scientific article published on April 7, 2011

High-density lipoprotein (HDL) promotes angiogenesis via S1P3-dependent VEGFR2 activation.

scientific article published on 15 February 2018

LBH-589 (panobinostat) potentiates fludarabine anti-leukemic activity through a JNK- and XIAP-dependent mechanism

scientific article published on November 8, 2011

Methods to study cancer therapeutic drugs that target cell cycle checkpoints

scientific article published on January 1, 2011

Poly(ADP-ribose) Polymerase 1 Modulates the Lethality of CHK1 Inhibitors in Mammary Tumors

scientific article published on May 17, 2012

Proteasome inhibitors potentiate leukemic cell apoptosis induced by the cyclin-dependent kinase inhibitor flavopiridol through a SAPK/JNK- and NF-κB-dependent process

scientific article published on October 16, 2003

Resveratrol Sensitizes Acute Myelogenous Leukemia Cells to Histone Deacetylase Inhibitors through Reactive Oxygen Species-Mediated Activation of the Extrinsic Apoptotic Pathway

scientific article published on August 24, 2012

The NAE inhibitor pevonedistat interacts with the HDAC inhibitor belinostat to target AML cells by disrupting the DDR.

scientific article published on 5 February 2016

The proteasome inhibitor bortezomib promotes mitochondrial injury and apoptosis induced by the small molecule Bcl-2 inhibitor HA14-1 in multiple myeloma cells

scientific article published on October 1, 2003